2nd Quarter - Report

FIERCE GOVERNMENT RELATIONS for MOMENTA PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to the Biologics Price Competition and Innovation Act, Risk Evaluation Mitigation Strategies, industry user fees, S.934 - FDA Reauthorization Act of 2017, H.R. 2430-FDA Reauthorization Act of 2017

LobbyistCovered position, as disclosed
WILLIAM KIRK BLALOCK —
KIRSTEN CHADWICK —
MICHAEL CHAPPELL —
KATE HULL —
ALEIX JARVIS —
DANIELLE MAURER —
WILLIAM PIPER —
TYLER STEPHENS —
ERIC ZULKOSKY New Director of Member Services, Majority Whip Steve Scalise, LD, Rep. Scalise, LA, Rep. Scalise, LA, Sen. Johanns, LC, Sen. Johanns, LC Sen. Dole, Mail Manager, Sen. Dole, Staff Assistant, Sen. Dole

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 934 (115th), H.R. 2430 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.